- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 117.4M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $850.26M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $852.1M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $8.73M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $8.73M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $127.48M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $146.01M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $104.03M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $115.13M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.09B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.1B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $291.96M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $303.71M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.79B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.8B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 117.45M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $17.37M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $36.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $711.36M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $705.46M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $21.6M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.22M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $13.95M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $39.22M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $121.31M |
| Revenue | Q1 2025 · Mar 31, 2024 | $160.54M |